General Counsel of $WTS sells 5,025 shares in insider sale

Kenneth Robert Lepage, the General Counsel of $WTS, recently sold 5,025 shares of the company on 02-17-2026 for an estimated $1,613,427, representing about 29.0% of their shares of this class of stock. After this transaction, Lepage currently holds 12,284 shares of this class of $WTS stock.

Over the past 6 months, $WTS insiders have engaged in 6 trades on the open market, with all 6 being sales and none being purchases. Other notable recent insider trades include Timothy P Horne selling 14,750 shares for around $4,060,935, Michael J. Dubose selling 727 shares for approximately $201,189, and Virginia A. Halloran, the Chief Accounting Officer, selling 605 shares for an estimated $167,451.

In terms of hedge fund activity involving $WTS stock, 201 institutional investors have increased their shares of $WTS stock in their portfolios, while 245 have decreased their positions in the most recent quarter. Significant recent moves include UBS AM, a distinct business unit of UBS Asset Management Americas LLC, removing 198,263 shares (-74.2%) from their portfolio in Q4 2025, and Kayne Anderson Rudnick Investment Management LLC removing 178,726 shares (-7.7%) from their portfolio in the same quarter.

For the fourth quarter of 2025, $WTS reported revenues of $625.1M, showing a 15.67% increase from the previous year. This financial data can be tracked on Quiver Quantitative’s WTS stock page.

Wall Street analyst reports on $WTS have indicated one firm issuing a buy rating on the stock, with zero firms issuing sell ratings. Keybanc recently issued an “Overweight” rating on 01/21/2026 for $WTS stock.

Multiple analysts have provided price targets for $WTS in the last 6 months, with a median target of $330.0. Recent price targets include Brian Lee from Goldman Sachs setting a target price of $323.0 on 02/17/2026, William Grippin from Barclays also setting a target price of $323.0 on 02/13/2026, and Jeffrey Reive from RBC Capital setting a target price of $337.0 on 02/13/2026.

It is important to note that the information shared in this article is not financial advice. Readers are encouraged to refer to Quiver Quantitative’s disclaimers for more information.